Ischemia induces phospholamban dephosphorylation via activation of calcineurin, PKC-α, and protein phosphatase 1, thereby inducing calcium overload in reperfusion

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 7, 2011, Pages 743-751

  Shintani Ishida, Kaori ^a   Yoshida, Ken ichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Calcineurin; Calcium; Ischemia; Phospholamban; Protein kinase C

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CALPAIN; CYCLOSPORIN A; FODRIN; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE 1; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HEART CONTRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION;

ANIMALS; BLOTTING, WESTERN; CALCINEURIN; CALCIUM; CALCIUM-BINDING PROTEINS; ISCHEMIA; MALE; PHOSPHORYLATION; PROTEIN KINASE C-ALPHA; PROTEIN PHOSPHATASE 1; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION;

RATTUS;

EID: 79955584660     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.03.014     Document Type: Article

References (44)

1. 2+-ATPase activity in guinea pig ventricles. J. Biol. Chem. 1983, 258:464-471.
2. 16 phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc. Res. 2002, 53:382-391.
3. 2+-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J. Mol. Cell. Cardiol. 1999, 31:479-491.
4. Munch G., Bolck B., Karczewski P., Schwinger R.H.G. Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium. J. Mol. Cell. Cardiol. 2002, 34:321-334.
5. i protein, phosphodiesterase, and phosphatases. Circ. Res. 1999, 85:848-855.
6. Dieterle T., Meyer M., Gu Y., Belke D.D., Swanson E., Iwatate M., Hollander J., Peterson K.L., Ross J.J., Dillmann W.H. Gene transfer of a phospholamban-targeted antibody improves calcium handling and cardiac function in heart failure. Cardiovasc. Res. 2005, 67:678-688.
7. Meyer M., Belke D.D., Trost S.U., Swanson E., Dieterle T., Scott B., Cary S.P., Ho P., Bluhm W.F., McDonough P.M., Silverman G.J., Dillmann W.H. A recombinant antibody increases cardiac contractility by mimicking phospholamban phosphorylation. FASEB J. 2004, 18:1312-1314.
8. 2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H310-H317.
9. Berrebi-Bertrand I., Souchet M., Camelin J.C., Laville M.P., Calmels T., Bril A. Biophysical interaction between phospholamban and protein phosphatase 1 regulatory subunit GM. FEBS Lett. 1998, 439:224-230.
10. Foulkes J.G., Strada S.J., Henderson P.J., Cohen P. A kinetic analysis of the effects of inhibitor-1 and inhibitor-2 on the activity of protein phosphatase-1. Eur. J. Biochem. 1983, 132:309-313.
11. Nicolaou P., Rodriguez P., Ren X., Zhou X., Qian J., Sadayappan S., Mitton B., Pathak A., Robbins J., Hajjar R.J., Jones K., Kranias E.G. Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury. Circ. Res. 2009, 104:1012-1020.
12. Endo S., Zhou X., Connor J., Wang B., Shenolikar S. Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor. Biochemistry 1996, 35:5220-5228.
13. El-Armouche A., Pamminger T., Ditz D., Zolk O., Eschenhagen T. Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovasc. Res. 2004, 61:87-93.
14. El-Armouche A., Gocht F., Jaeckel E., Wittkopper K., Peeck M., Eschenhagen T. Long-term β-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart. Eur. J. Heart Fail. 2007, 9:1077-1080.
15. Braz J.C., Gregory K., Pathak A., Zhao W., Sahin B., Klevitsky R., Kimball T.F., Lorenz J.N., Nairn A.C., Liggett S.B., Bodi I., Wang S., Schwartz A., Lakatta E.G., DePaoli-Roach A.A., Robbins J., Hewett T.E., Bibb J.A., Westfall M.V., Kranias E.G., Molkentin J.D. PKC-α regulates cardiac contractility and propensity toward heart failure. Nat. Med. 2004, 10:248-254.
16. Rodriguez P., Mitton B., Waggoner J.R., Kranias E.G. Identification of a novel phosphorylation site in protein phosphatase inhibitor-1 as a negative regulator of cardiac function. J. Biol. Chem. 2006, 281:38599-38608.
17. 75 attenuates stimulatory effects of protein kinase A signaling in cardiac myocytes. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H762-H769.
18. Yoshida K., Hirata T., Akita Y., Mizukami Y., Yamaguchi K., Sorimachi Y., Ishihara T., Kawashiama S. Translocation of protein kinase C-α, δ and ε isoforms in ischemic rat heart. Biochim. Biophys. Acta 1996, 1317:36-44.
19. MacDonnell S.M., Kubo H., Harris D.M., Chen X., Berretta R., Barbe M.F., Kolwicz S., Reger P.O., Eckhart A., Renna B.F., Koch W.J., Houser S.R., Libonati J.R. Calcineurin inhibition normalizes β-adrenergic responsiveness in the spontaneously hypertensive rat. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3122-H3129.
20. Ikeda Y., Miura T., Sakamoto J., Miki T., Tanno M., Kobayashi H., Ohori K., Takahashi A., Shimamoto K. Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by δ-opioid receptor activation. Basic Res. Cardiol. 2006, 101:418-426.
21. Vincent F., Duquesnes N., Christov C., Damy T., Samuel J.L., Crozatier B. Dual level of interactions between calcineurin and PKC-ε in cardiomyocyte stretch. Cardiovasc. Res. 2006, 71:97-107.
22. v4.2N transgenic mice. Circulation 2002, 105:1850-1856.
23. 2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J. Biol. Chem. 2000, 275:13571-13579.
24. Rodriguez-Sinovas A., Abdallah Y., Piper H.M., Garcia-Dorado D. Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction. Heart Fail. Rev. 2007, 12:207-216.
25. Shintani-Ishida K., Unuma K., Yoshida K. Ischemia enhances translocation of connexin43 and gap junction intercellular communication, thereby propagating contraction band necrosis after reperfusion. Circ. J. 2009, 73:1661-1668.
26. Yoshida K., Inui M., Harada K., Saido T.C., Sorimachi Y., Ishihara T., Kawashima S., Sobue K. Reperfusion of rat heart after brief ischemia induces proteolysis of calspectin (nonerythroid spectrin or fodrin) by calpain. Circ. Res. 1995, 77:603-610.
27. Murat A., Pellieux C., Brunner H.R., Pedrazzini T. Calcineurin blockade prevents cardiac mitogen-activated protein kinase activation and hypertrophy in renovascular hypertension. J. Biol. Chem. 2000, 275:40867-40873.
28. Tossidou I., Teng B., Menne J., Shushakova N., Park J.K., Becker J.U., Modde F., Leitges M., Haller H., Schiffer M. Podocytic PKC-α is regulated in murine and human diabetes and mediates nephrin endocytosis. PLoS One 2010, 5:e10185.
29. Saido T.C., Yokota M., Nagao S., Yamaura I., Tani E., Tsuchiya T., Suzuki K., Kawashima S. Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 1993, 268:25239-25243.
30. Inomata M., Nomura K., Takehana M., Saido T.C., Kawashima S., Shumiya S. Evidence for the involvement of calpain in cataractogenesis in Shumiya cataract rat (SCR). Biochim. Biophys. Acta 1997, 1362:11-23.
31. Futamatsu H., Suzuki J., Mizuno S., Koga N., Adachi S., Kosuge H., Maejima Y., Hirao K., Nakamura T., Isobe M. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ. Res. 2005, 96:823-830.
32. Vittone L., Mundina C., Chiappe de Cingolani G., Mattiazzi A. cAMP and calcium-dependent mechanisms of phospholamban phosphorylation in intact hearts. Am. J. Physiol. Heart. Cir. Physiol. 1990, 258:H318-H325.
33. 2+ leak through ryanodine receptor in heart failure. Circulation 2000, 102:2131-2136.
34. Cornea R.L., Jones L.R., Autry J.M., Thomas D.D. Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Biochemistry 1997, 36:2960-2967.
35. Thomas D.D., Reddy L.G., Karim C.B., Li M., Cornea R., Autry J.M., Jones L.R., Stamm J. Direct spectroscopic detection of molecular dynamics and interactions of the calcium pump and phospholamban. Ann. N.Y. Acad. Sci. 1998, 853:186-194.
36. 2+ uptake in mammalian ventricular myocytes. Am. J. Physiol. Heart. Cir. Physiol. 1991, 261:H1344-H1349.
37. Chohan P.K., Singh R.B., Dhalla N.S., Netticadan T. L-arginine administration recovers sarcoplasmic reticulum function in ischemic reperfused hearts by preventing calpain activation. Cardiovasc. Res. 2006, 69:152-163.
38. Kim S.J., Kudej R.K., Yatani A., Kim Y.K., Takagi G., Honda R., Colantonio D.A., Van Eyk E., Vatner D.E., Rasmusson R.L., Vatner S.F. A novel mechanism for myocardial stunning involving impaired Ca2+ handling. Circ. Res. 2001, 89:831-837.
39. El-Armouche A., Bednorz A., Pamminger T., Ditz D., Didie M., Dobrev D., Eschenhagen T. Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes. Biochem. Biophys. Res. Commun. 2006, 346:700-706.
40. Shintani-Ishida K., Uemura K., Yoshida K. Hemichannels in cardiomyocytes open transiently during ischemia and contribute to reperfusion injury following brief ischemia. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H1714-H1720.
41. Lakshmikuttyamma A., Selvakumar P., Kakkar R., Kanthan R., Wang R., Sharma R.K. Activation of calcineurin expression in ischemia-reperfused rat heart and in human ischemic myocardium. J. Cell. Biochem. 2003, 90:987-997.
42. 2+ channel. Circ. Res. 2009, 105:51-60.
43. Jeyaraman M., Tanguy S., Fandrich R.R., Lukas A., Kardami E. Ischemia-induced dephosphorylation of cardiomyocyte connexin-43 is reduced by okadaic acid and calyculin A but not fostriecin. Mol. Cell. Biochem. 2003, 242:129-134.
44. 2+ pump of sarcoplasmic reticulum. Nature 1989, 342:90-92.